These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 16677089)

  • 21. Methylene blue rescues heart defects in a Drosophila model of Friedreich's ataxia.
    Tricoire H; Palandri A; Bourdais A; Camadro JM; Monnier V
    Hum Mol Genet; 2014 Feb; 23(4):968-79. PubMed ID: 24105471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel aberrant genetic and epigenetic events in Friedreich's ataxia.
    Quesada MP; Jones J; Rodríguez-Lozano FJ; Moraleda JM; Martinez S
    Exp Cell Res; 2015 Jul; 335(1):51-61. PubMed ID: 25929520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Friedreich's ataxia--a case of aberrant transcription termination?
    Butler JS; Napierala M
    Transcription; 2015; 6(2):33-6. PubMed ID: 25831023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular insights into Friedreich's ataxia and antioxidant-based therapies.
    Rötig A; Sidi D; Munnich A; Rustin P
    Trends Mol Med; 2002 May; 8(5):221-4. PubMed ID: 12067631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stress.
    Gomes CM; Santos R
    Oxid Med Cell Longev; 2013; 2013():487534. PubMed ID: 23936609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic Prospects for Friedreich's Ataxia.
    Zhang S; Napierala M; Napierala JS
    Trends Pharmacol Sci; 2019 Apr; 40(4):229-233. PubMed ID: 30905359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia.
    Bradley JL; Blake JC; Chamberlain S; Thomas PK; Cooper JM; Schapira AH
    Hum Mol Genet; 2000 Jan; 9(2):275-82. PubMed ID: 10607838
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Calap-Quintana P; Navarro JA; González-Fernández J; Martínez-Sebastián MJ; Moltó MD; Llorens JV
    Biomed Res Int; 2018; 2018():5065190. PubMed ID: 29850527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Overview of the Ferroptosis Hallmarks in Friedreich's Ataxia.
    Turchi R; Faraonio R; Lettieri-Barbato D; Aquilano K
    Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33126466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the molecular mechanisms of Friedreich's ataxia to develop therapeutic approaches.
    Schmucker S; Puccio H
    Hum Mol Genet; 2010 Apr; 19(R1):R103-10. PubMed ID: 20413654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia.
    Perdomini M; Belbellaa B; Monassier L; Reutenauer L; Messaddeq N; Cartier N; Crystal RG; Aubourg P; Puccio H
    Nat Med; 2014 May; 20(5):542-7. PubMed ID: 24705334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipophilic methylene blue analogues enhance mitochondrial function and increase frataxin levels in a cellular model of Friedreich's ataxia.
    Khdour OM; Bandyopadhyay I; Chowdhury SR; Visavadiya NP; Hecht SM
    Bioorg Med Chem; 2018 Jul; 26(12):3359-3369. PubMed ID: 29773347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in mitochondrial glutathione levels and protein thiol oxidation in ∆yfh1 yeast cells and the lymphoblasts of patients with Friedreich's ataxia.
    Bulteau AL; Planamente S; Jornea L; Dur A; Lesuisse E; Camadro JM; Auchère F
    Biochim Biophys Acta; 2012 Feb; 1822(2):212-25. PubMed ID: 22200491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered lipid metabolism in a Drosophila model of Friedreich's ataxia.
    Navarro JA; Ohmann E; Sanchez D; Botella JA; Liebisch G; Moltó MD; Ganfornina MD; Schmitz G; Schneuwly S
    Hum Mol Genet; 2010 Jul; 19(14):2828-40. PubMed ID: 20460268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of PGC-1α and metabolic sensors suggest age-dependent induction of mitochondrial biogenesis in Friedreich ataxia fibroblasts.
    García-Giménez JL; Gimeno A; Gonzalez-Cabo P; Dasí F; Bolinches-Amorós A; Mollá B; Palau F; Pallardó FV
    PLoS One; 2011; 6(6):e20666. PubMed ID: 21687738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Friedreich's ataxia and iron metabolism.
    Gordon N
    Brain Dev; 2000 Dec; 22(8):465-8. PubMed ID: 11111058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infectious delivery and expression of a 135 kb human FRDA genomic DNA locus complements Friedreich's ataxia deficiency in human cells.
    Gomez-Sebastian S; Gimenez-Cassina A; Diaz-Nido J; Lim F; Wade-Martins R
    Mol Ther; 2007 Feb; 15(2):248-54. PubMed ID: 17235301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic approaches for the treatment of Friedreich's ataxia.
    Strawser CJ; Schadt KA; Lynch DR
    Expert Rev Neurother; 2014 Aug; 14(8):949-57. PubMed ID: 25034024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial pathophysiology in Friedreich's ataxia.
    González-Cabo P; Palau F
    J Neurochem; 2013 Aug; 126 Suppl 1():53-64. PubMed ID: 23859341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.